S. Gayther

发表

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

J Chang-Claude, M. Stratton, J. Chang-Claude, 1998, American journal of human genetics.

Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.

Kylie L. Gorringe, B. Ponder, C. Caldas, 1998, Cancer research.

Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing.

B. Ponder, S. Gayther, S. Gayther, 1997, Molecular medicine today.

Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.

B. Ponder, I. Jacobs, Ian A. Scott, 1996, Cancer research.

Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.

B. Ponder, D. Easton, P. Pharoah, 1999, Cancer research.

Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group.

B. Ponder, S. Gayther, S. Gayther, 1996, American journal of human genetics.

In vitro three‐dimensional modelling of human ovarian surface epithelial cells

I. Jacobs, E. Benjamin, S. Gayther, 2009, Cell proliferation.

Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.

B. Ponder, Z. Kote-Jarai, S. Gayther, 1997, American journal of human genetics.

Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

B. Ponder, S. Gayther, P. Harrington, 1997, American journal of human genetics.

Prevalence and penetrance of mutations in BRCA1 and BRCA2 in a population based series of breast cancer cases

B. Ponder, S. Gayther, D. Easton, 2000 .

Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.

B. Ponder, C. Healey, L. Mulligan, 1996, British Journal of Cancer.

Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: Implications for genetic testing

B. Ponder, D. Easton, P. Pharoah, 2001, Genes, chromosomes & cancer.

Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas.

B. Ponder, M. Evans, W. Colledge, 1998, British Journal of Cancer.

Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.

B. Ponder, H. Anton-Culver, G. Casey, 1997, American journal of human genetics.

The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.

B. Ponder, D. Easton, A. Antoniou, 1999, American journal of human genetics.

Genetic intra‐tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours

I. Jacobs, M. Weale, I. Jacobs, 2007, The Journal of pathology.

The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

M. Beckmann, T. Sellers, M. Stratton, 2000, American journal of human genetics.

A gene (DLG2) located at 17q12-q21 encodes a new homologue of the Drosophila tumor suppressor dIg-A.

B. Ponder, R. White, S. Mazoyer, 1995, Genomics.

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Jane E. Carpenter, A. Whittemore, W. Chung, 2016, Nature Communications.